Abstract

Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-β (Aβ) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of Aβ is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of Aβ. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on Aβ accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of Aβ, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBI. The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies.

Original languageEnglish
Pages (from-to)99-104
Number of pages6
JournalJournal of the Neurological Sciences
Volume349
Issue number1-2
DOIs
Publication statusPublished - Feb 15 2015

Fingerprint

Brain Concussion
Amyloid
Alzheimer Disease
Positron-Emission Tomography
Apolipoproteins E
Neurodegenerative Diseases
Neurofibrillary Tangles
Cognitive Dysfunction
Amyloid Plaques
Research
Gene Frequency
Epidemiology
Alleles
Research Personnel
Pathology

Keywords

  • Alzheimer disease
  • Amyloid PET
  • Cognitive impairment
  • Genetics
  • Mild traumatic brain injury
  • Neurodegenerative diseases

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Accumulation of amyloid in cognitive impairment after mild traumatic brain injury. / Yang, Shung Tai; Hsiao, Ing Tsung; Hsieh, Chia Ju; Chiang, Yung Hsiao; Yen, Tzu Chen; Chiu, Wen Ta; Lin, Kun Ju; Hu, Chaur Jong.

In: Journal of the Neurological Sciences, Vol. 349, No. 1-2, 15.02.2015, p. 99-104.

Research output: Contribution to journalArticle

Yang, Shung Tai ; Hsiao, Ing Tsung ; Hsieh, Chia Ju ; Chiang, Yung Hsiao ; Yen, Tzu Chen ; Chiu, Wen Ta ; Lin, Kun Ju ; Hu, Chaur Jong. / Accumulation of amyloid in cognitive impairment after mild traumatic brain injury. In: Journal of the Neurological Sciences. 2015 ; Vol. 349, No. 1-2. pp. 99-104.
@article{414e06e43c9e476799959fc5710e9a3e,
title = "Accumulation of amyloid in cognitive impairment after mild traumatic brain injury",
abstract = "Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-β (Aβ) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of Aβ is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of Aβ. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on Aβ accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of Aβ, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBI. The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies.",
keywords = "Alzheimer disease, Amyloid PET, Cognitive impairment, Genetics, Mild traumatic brain injury, Neurodegenerative diseases",
author = "Yang, {Shung Tai} and Hsiao, {Ing Tsung} and Hsieh, {Chia Ju} and Chiang, {Yung Hsiao} and Yen, {Tzu Chen} and Chiu, {Wen Ta} and Lin, {Kun Ju} and Hu, {Chaur Jong}",
year = "2015",
month = "2",
day = "15",
doi = "10.1016/j.jns.2014.12.032",
language = "English",
volume = "349",
pages = "99--104",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Accumulation of amyloid in cognitive impairment after mild traumatic brain injury

AU - Yang, Shung Tai

AU - Hsiao, Ing Tsung

AU - Hsieh, Chia Ju

AU - Chiang, Yung Hsiao

AU - Yen, Tzu Chen

AU - Chiu, Wen Ta

AU - Lin, Kun Ju

AU - Hu, Chaur Jong

PY - 2015/2/15

Y1 - 2015/2/15

N2 - Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-β (Aβ) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of Aβ is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of Aβ. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on Aβ accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of Aβ, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBI. The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies.

AB - Recent epidemiology studies have indicated that traumatic brain injury (TBI) can increase the risk of developing neurodegenerative diseases such as Alzheimer's disease (AD). Amyloid-β (Aβ) plaques and neurofibrillary tangles are pathological indicators of AD. The accumulation of Aβ is considered the first step of AD pathophysiology. Compelling studies have supported the hypothesis that TBI accelerates the formation and accumulation of Aβ. These findings could link TBI with AD, although the research that reported these findings had limitations, particularly regarding mild TBI (mTBI) patients. The effects of mTBI on Aβ accumulation remain uncertain because of a lack of mTBI pathology data. Using amyloid-positron emission tomography (amyloid-PET), researchers can help to determine whether mTBI increases the accumulation of Aβ, which might be involved in the pathophysiological mechanisms of mTBI in AD, and could be a target for the treatment of neurodegenerative diseases associated with TBI. In this study, we recruited 27 mTBI patients with mTBI in mean 6 years before this study (21 mTBI patients without cognitive impairment, 6 mTBI patients with cognitive impairment,) and 10 controls. All of them underwent mini-mental state examination, apolipoprotein E (APOE) genotyping, and amyloid-PET. The results show an increase of amyloid accumulation and allele frequency of APOE4 in the mTBI patients with cognitive impairment. These findings indicate that amyloid accumulation is an important indicator of cognitive impairment, and amyloid-PET should be a safe and useful tool for diagnosing amyloid-related cognitive impairment. APOE allele might play a role in the occurrence of cognitive impairment after mTBI. The contribution of mTBI to the amyloid accumulation requires further study, and mTBI patients should be recruited for longitudinal research with repeated amyloid-PET studies.

KW - Alzheimer disease

KW - Amyloid PET

KW - Cognitive impairment

KW - Genetics

KW - Mild traumatic brain injury

KW - Neurodegenerative diseases

UR - http://www.scopus.com/inward/record.url?scp=84923964434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923964434&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2014.12.032

DO - 10.1016/j.jns.2014.12.032

M3 - Article

C2 - 25586534

AN - SCOPUS:84923964434

VL - 349

SP - 99

EP - 104

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -